Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/27/1993 | CA2083345A1 Cephalosporin derivatives |
05/26/1993 | EP0543780A2 Novel aminoalkanephosphinic acids and their salts |
05/26/1993 | EP0543713A1 Ethanolamine benzoate derivatives, process for their preparation and pharmaceutical compositions containing them |
05/26/1993 | EP0543662A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
05/26/1993 | EP0543659A1 Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma |
05/26/1993 | EP0543653A1 Dipyridamole for the treatment of proliferative diseases |
05/26/1993 | EP0543584A1 Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system |
05/26/1993 | EP0543555A1 Phosphorylated flavanoids in the treatment of viral diseases |
05/26/1993 | EP0543541A1 Controlled release flutamide composition |
05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
05/26/1993 | EP0543516A1 Hapalindole alkaloids as antifungal and antitumor agents |
05/26/1993 | EP0543497A1 Tricyclic thienothiopyrans as antiglancoma agents |
05/26/1993 | EP0543491A2 Angiotensin II antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering |
05/26/1993 | EP0543476A1 Use of interleukin-8 |
05/26/1993 | EP0543454A2 Encapsulated particles useful as contrast agents in ultrasound and X-ray imaging compositions and methods |
05/26/1993 | EP0543417A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
05/26/1993 | EP0543310A2 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same |
05/26/1993 | EP0543245A1 Renin inhibiting amino acid derivatives |
05/26/1993 | EP0543201A2 Alkoxylated phenyl and coumarin derivatives, their production and use for the manufacture of medicaments |
05/26/1993 | EP0543088A1 Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
05/26/1993 | EP0543018A1 Antidiabetic agent |
05/26/1993 | EP0543015A1 Composition, method and kit for potentiating antitumor activity and for curing tumor |
05/26/1993 | EP0543004A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
05/26/1993 | EP0543001A1 Use of antiarrhythmic agents to lower cholesterol |
05/26/1993 | EP0542988A1 Improved euthanasia compositions |
05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay |
05/26/1993 | EP0542941A1 N-phenyl-benzamides providing protection from the harmful effects of ultraviolet light. |
05/26/1993 | EP0542930A1 Oral pharmaceutical compositions containing melatonin. |
05/26/1993 | EP0542912A1 Calcium and trace mineral supplements. |
05/26/1993 | EP0542879A1 Process for formulating a solid oral dosage form of loperamide compounds |
05/26/1993 | EP0542867A1 Methods of preventing or decreasing tissue damage by novel antioxidants and free radical scavengers |
05/26/1993 | EP0542864A1 Treatment for hypercholesterolemia. |
05/26/1993 | EP0542860A1 Immunosuppressive compositions |
05/26/1993 | EP0542846A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
05/26/1993 | EP0542844A1 3-substituted piperidine derivatives |
05/26/1993 | EP0542841A1 New synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof. |
05/26/1993 | EP0542822A1 Viral (hiv) growth inhibition |
05/26/1993 | EP0542816A1 Oxazolidine dione derivatives |
05/26/1993 | EP0542814A1 Neuroprotection by indolactam v and derivatives thereof |
05/26/1993 | EP0542807A1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one |
05/26/1993 | EP0542795A1 Tnf inhibitors |
05/26/1993 | EP0540686A4 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
05/26/1993 | EP0532530A4 Derivatives of 6-aminooctahydroindolizinetriol |
05/26/1993 | EP0531282A4 Production and use of porphyrin derivatives and of compositions containing such derivatives |
05/26/1993 | EP0527891A4 Biodegradable polyesters for sustained drug delivery |
05/26/1993 | EP0435915B1 Compositions for the treatment of leishmaniasis |
05/26/1993 | EP0418327B1 Antiemesis ergoline derivatives |
05/26/1993 | EP0401256B1 Optically pure dexniguldipine and its derivatives for treating tumorous diseases |
05/26/1993 | EP0228415B1 Increasing aqueous humor outflow |
05/26/1993 | CN1072413A 氨基酸衍生物 Amino acid derivatives |
05/26/1993 | CN1072411A Therapeutically active compound |
05/26/1993 | CN1072408A Process for preparing 13, 14-dihydro-15(r)-17-phenyl-18'19'20-trinor-pgf 2 alpha esters |
05/26/1993 | CN1072338A Pharmaceutical compositions for oral use and method of preparing them |
05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
05/26/1993 | CN1020906C Process for preparation of 2-(heterocyclylalkyl) imidazopyridines compounds |
05/26/1993 | CN1020903C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives and the preparation therefor |
05/26/1993 | CN1020902C Imidazole derivative and processes for preparing same |
05/26/1993 | CN1020900C Method for preparation of substituted n-(3-hydroxy-4-piperidinyl) benzamides |
05/26/1993 | CN1020899C Method for preparation of pyrrolidine derivatives |
05/26/1993 | CN1020897C Process for preparing of pentamidine salts useful in treatment and prophylaxis of pneumocystis carinii pneumonia |
05/26/1993 | CN1020893C Improved process for preparing vinyl ethers |
05/26/1993 | CN1020853C Tricyclic compounds, their preparation and pharmaceutical composition containing them |
05/26/1993 | CN1020852C New pharmaceutical preparation for oral use |
05/26/1993 | CA2082462A1 Azole derivatives |
05/26/1993 | CA2082333A1 Heterocyclic compounds |
05/26/1993 | CA2082332A1 Chemical process |
05/25/1993 | US5214206 Anticholesterol agents, inhibitors of acylcoenzyme A |
05/25/1993 | US5214204 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
05/25/1993 | US5214202 Method for preparing benzoic acid derivatives |
05/25/1993 | US5214191 Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
05/25/1993 | US5214180 Plant extracts, protecting hydroxy groups, solvent extraction, chromatography |
05/25/1993 | US5214071 Corneal treatment agents |
05/25/1993 | US5214067 Fungicidal compositions and method |
05/25/1993 | US5214066 Method for producing an animal model for inflammatory bowel disease including ulcerative colitis |
05/25/1993 | US5214062 Method and composition for treating immune disorders, inflammation and chronic infections |
05/25/1993 | US5214060 Pyridylalkylpiperidine or pyrolidine |
05/25/1993 | US5214053 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same |
05/25/1993 | US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them |
05/25/1993 | US5214050 Esters of castanospermine in the treatment of cerebral malaria |
05/25/1993 | US5214047 Tetracyclic quinazoline derivatives, effective as antiarrythmic agents |
05/25/1993 | US5214045 Acrylamides having amide substituted by residues of glycine, alanine, aspartic acid, methionine, proline or thiazolidinecarboxylic acid and acrylic group substituted by phenylthio-, phenylsulfinyl- or phenylsulfonyl-groups |
05/25/1993 | US5214042 Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents |
05/25/1993 | US5214040 Side effect reduction |
05/25/1993 | US5214038 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
05/25/1993 | US5214037 Antibiotic, bactericide |
05/25/1993 | US5214036 Benzoporphyrin derivatives for photodynamic therapy |
05/25/1993 | US5214035 Animal antifertility agents, altrenogest |
05/25/1993 | US5214034 Improved secretion of nerve growth factor |
05/25/1993 | US5213807 Pharmaceutical composition containing ibuprofen and a prostaglandin |
05/25/1993 | US5213806 And cellulose derivative, laxative, antidiarrhea agent |
05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
05/25/1993 | US5213794 Antacid preparation having a prolonged gastric residence time |
05/25/1993 | US5213615 Sustained release of thymol or carvacrol and chlorhexidine, anticaries agents, dentistry |
05/25/1993 | CA1318325C 1-substituted tetralin derivatives, their preparation and their use |
05/25/1993 | CA1318318C Polycyclic ether antibiotics |
05/25/1993 | CA1318317C Preparation of a new diosmine derivative |
05/25/1993 | CA1318254C Inhibitory agent of hepatic fibrosis containing pantethine |
05/25/1993 | CA1318253C Stabilized pergolide compositions |
05/25/1993 | CA1318251C Combined use of an antigestagen and a progesterone systhesis inhibitor of the trilostane and epostane type |
05/25/1993 | CA1318172C Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |